3Andersson S, Safari H, Mints M. Type distribution, viral load and integration status of high-risk human papillomavirus in prestages of cervical cancer. Br J Cancer,2005,92:2195-2200.
4Fait G,Kupferminc MJ,Daniel Y,et al. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnomal papsmears before colposcopy referral. Gyneed 0ncol,2000,79(2) : 177-180.
5Braganca JF,Derchain SFF,Zeferino LC,et al. Aided visual in-spection with acetic acid (VIA) and HPV detection as optional screening tools for cervical cancer and its precurson leisions. Clin Exp Obstet Gynecol, 2005,32(4):225-229.
6Ronco G,Giorgi-Rossi P, Cuzick J,et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years:results at recruitment for a randomized controlled trial. Lancet Oncol, 2006,7(7):547-555.
7Ronco G,Segnan N,Cuzick J,et al. Human papillomavims testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst, 2006,98(11) :765-774.
9Thierry F. Transcriptional regulation of the papillomavirus onco- genes by cellular and viral transcription factors in cervical carci- noma. Virology, 2009, 384(2): 375-379.
10Bocking A. Nguyen V Q. Diagnostic and prognostic use of DNA image cytometry in cervical squamous intraepithelial le- sions and invasive carcinoma J]. Cancer, 2004, 102 (1).- 41- 54.
